Clinical and biologic effects of granulocyte colony stimulating factor in the treatment of myelokathexis
- 28 February 1991
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 118 (2) , 229-234
- https://doi.org/10.1016/s0022-3476(05)80488-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Myelokathexis associated with multiple congenital malformations: Immunological study on phagocytic cells and lymphocytesEuropean Journal of Haematology, 2009
- Cytochrome b deficiency in an autosomal form of chronic granulomatous disease. A third form of chronic granulomatous disease recognized by monocyte hybridization.Journal of Clinical Investigation, 1985
- Myelokathexis: a rare form of chronic benign granulocytopeniaBritish Journal of Haematology, 1984
- Myelokathexis: Chronic neutropenia with hyperplastic bone marrow and hypersegmented neutrophils in two siblingsAnnals of Hematology, 1981
- Consequences of vitamin-E deficiency on the phagocytic and oxidative functions of the rat polymorphonuclear leukocyteBlood, 1980
- 'Myelokathexis'American Journal of Diseases of Children, 1977
- Biological Defense Mechanisms THE EFFECT OF BACTERIA AND SERUM ON SUPEROXIDE PRODUCTION BY GRANULOCYTESJournal of Clinical Investigation, 1974
- LEUKOCYTE LOCOMOTION AND CHEMOTAXISThe Journal of Experimental Medicine, 1973
- Chronic Idiopathic GranulocytopeniaNew England Journal of Medicine, 1964
- Myelokathexis — A New Form of Chronic GranulocytopeniaNew England Journal of Medicine, 1964